As I said they have had three years to get that going. You have to ask yourself why couldn't they raise money from the private sector if it is so good? Why tie this to a BS company like EPGL? For starters they put out in their last PR that the annual potential for this device was $3.5 billion when, in fact, that is the total world-wide potential. Starting out with more BS is not going to help.
From your own DD you found that the average cost of bringing a medical device to the market is $24 MM. Where is EPGL going to raise that kind of money? How much dilution is that going to cost?
EP has been a loosing proposition for so many years and that is not going to change. Having a second albatross around their neck certainly will not help.
If EP is going to have any chance of getting this restructuring passed, they will have to convince shareholders that their is something in it for them. So far, this company has shown nothing but distain for their shareholders and I do not see that changing.
Market Data 
Markets 
